Feature | March 19, 2010

Radiation Oncologist Strengthens ITN’s Advisory Board

Vivek Mehta, M.D., is a radiation oncologist at Swedish Cancer Institute, Seattle, and a new member of the ITN Editorial Advisory Board.

Radiation oncology is an important area of concentration for Imaging Technology News (ITN), as we provide coverage of radiation therapy technology, treatment planning solutions and data management systems specifically for radiation oncology.

As we strive to further strengthen our expertise in this field, I am honored to welcome Vivek Mehta, M.D., a radiation oncologist at Swedish Cancer Institute, Seattle, to the ITN Editorial Advisory Board.
Dr. Mehta joined Swedish Cancer Institute in 2002, and is actively involved in designing and developing clinical research studies at Swedish Cancer Institute and through national research organizations, including the Southwestern Oncology Group.

His clinical interests include image-guided radiotherapy, balloon catheter-based breast brachytherapy, gamma knife radiosurgery, intensity modulated radiotherapy, stereotactic radiosurgery, and three-dimensional conformal radiotherapy.

Dr. Mehta has been involved in a number of clinical research studies and has been widely published in medical journals and publications. He has written several articles evaluating the use of concurrent chemotherapy and radiation in the management of malignancy, which he also presented at national and international meetings. His research has appeared in the peer-reviewed International Journal of Radiation Oncology, Biology and Physics, the American Journal of Clinical Oncology, Archives of Surgery, and the Journal of Gastrointestinal Surgery.

A graduate of Georgetown University, Dr. Mehta earned his medical degree from the University of Washington and completed his internship at both the Legacy Good Samaritan Medical Center and Legacy Emanuel Hospital in Portland, Ore. He completed his residency at Stanford University Medical, where he also served as chief resident in the radiation oncology department. He is board certified in therapeutic radiology.

In 2004 and 2006, Seattle magazine named Dr. Mehta one of the city’s top doctors in the area of radiation oncology. Other accolades include numerous resident/fellow research awards, such as the Malcolm A. Bagshaw Radiation Oncology Resident Award. He is the current scientific program chair for the Washington State Radiation Oncology Society and is also active in the American Society of Therapeutic Radiation Oncologists, the American College of Radiology and the American Association of Indian Physicians, and the American Society of Clinical Oncology.
In addition to his work at the Swedish Cancer Institute, Dr. Mehta is an assistant clinical professor at the University of Washington School of Medicine. To contact Dr. Mehta, e-mail him at: [email protected]

Related Content

Clinical Trial Testing Topical Gel to Reduce Breast Density
News | Breast Density | June 19, 2018
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast...
New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
California Women In Favor of Extending State's Breast Density Inform Law
News | Breast Density | June 15, 2018
A recent survey of California women found that 95 percent of respondents want the state’s breast density inform law to...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
Women More Likely to Use Other Preventive Health Services Following Mammography
News | Mammography | June 13, 2018
Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
How AI and Deep Learning Will Enable Cancer Diagnosis Via Ultrasound

The red outline shows the manually segmented boundary of a carcinoma, while the deep learning-predicted boundaries are shown in blue, green and cyan. Copyright 2018 Kumar et al. under Creative Commons Attribution License.

News | Ultrasound Imaging | June 12, 2018 | Tony Kontzer
June 12, 2018 — Viksit Kumar didn’t know his mother had...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Overlay Init